Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45‐related factor‐2 expression in osteoblastic MC3T3‐E1 cells

Activation of particular glutamate (Glu) receptors is shown to promote cellular differentiation toward maturation during osteoblastogenesis. In the present study, we have evaluated the possible modulation by Glu of cellular proliferation in osteoblastic cells endowed to proliferate for self‐renewal and to differentiate toward matured osteoblasts. Exposure to Glu significantly suppressed the proliferation activity at a concentration over 500 µM without inducing cell death in osteoblastic MC3T3‐E1 cells before differentiation. The suppression by Glu occurred in a manner sensitive to the prevention by either cystine or reduced glutathione. Expression of mRNA was for the first time shown with the cystine/Glu antiporter composed of xCT and 4F2hc subunits in these undifferentiated osteoblastic cells. A significant decrease was seen in intracellular total glutathione levels in undifferentiated MC3T3‐E1 cells cultured with Glu, indeed, whereas the cellular proliferation activity was drastically decreased by the addition of the glutathione depleter cyclohexene‐1‐one and the glutathione biosynthesis inhibitor L‐buthionine‐[S,R]‐sulfoximine, respectively. Exposure to Glu led to a significant increase in mRNA expression of nuclear factor E2 p45‐related factor 2 (Nrf2) together with the generation of reactive oxygen species, while a significant decrease was seen in the proliferation activity in MC3T3‐E1 cells with stable overexpression of Nrf2. These results suggest that Glu could suppress the cellular proliferation toward self‐renewal through a mechanism associated with the upregulation of Nrf2 expression in association with the depletion of intracellular glutathione after promoting the retrograde operation of the cystine/Glu antiporter in undifferentiated MC3T3‐E1 cells. J. Cell. Physiol. 213: 105–114, 2007. © 2007 Wiley‐Liss, Inc.

[1]  F. Ciruela,et al.  Glutamate Released by Dendritic Cells as a Novel Modulator of T Cell Activation1 , 2006, The Journal of Immunology.

[2]  T. Murphy,et al.  Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation , 2006, The Journal of Neuroscience.

[3]  N. Nakamichi,et al.  Glutamate Inhibits Chondral Mineralization through Apoptotic Cell Death Mediated by Retrograde Operation of the Cystine/Glutamate Antiporter* , 2006, Journal of Biological Chemistry.

[4]  E. Hinoi,et al.  Nrf2 Negatively Regulates Osteoblast Differentiation via Interfering with Runx2-dependent Transcriptional Activation* , 2006, Journal of Biological Chemistry.

[5]  E. Hinoi,et al.  Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage , 2005, British journal of pharmacology.

[6]  Y. Surh,et al.  Nrf2 as a novel molecular target for chemoprevention. , 2005, Cancer letters.

[7]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[8]  S. Goff,et al.  Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. , 2004, Genes & development.

[9]  T. Ueshima,et al.  Accumulation of [3H] glutamate in cultured rat calvarial osteoblasts. , 2004, Biochemical pharmacology.

[10]  K. Itoh,et al.  Nrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[11]  G. Gordon,et al.  A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. , 2004, Molecular cancer therapeutics.

[12]  C. Albanese,et al.  The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame (INK4a/ARF) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Distinct cis Elements , 2004, Cancer Research.

[13]  E. Moran,et al.  Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. , 2003, Experimental cell research.

[14]  E. Hinoi,et al.  Modulation of cellular differentiation by N‐methyl‐d‐aspartate receptors in osteoblasts , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  E. Hinoi,et al.  Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. , 2002, Biochemical and biophysical research communications.

[16]  E. Hinoi,et al.  Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts , 2002, Brain Research.

[17]  P. Genever,et al.  Glutamate signalling in non-neuronal tissues. , 2001, Trends in pharmacological sciences.

[18]  E. Hinoi,et al.  Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. , 2001, Biochemical and biophysical research communications.

[19]  K. Westlund,et al.  Amino acid release into the knee joint: key role in nociception and inflammation , 2000, Pain.

[20]  K. Westlund,et al.  Excitatory amino acid profiles of synovial fluid from patients with arthritis. , 2000, The Journal of rheumatology.

[21]  L. Suva,et al.  Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. , 1999, Bone.

[22]  T. Skerry,et al.  The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  T. Ishii,et al.  Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins* , 1999, The Journal of Biological Chemistry.

[24]  P. Delmas,et al.  Glutamate receptors are expressed by bone cells and are involved in bone resorption. , 1998, Bone.

[25]  W. Willis,et al.  Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. , 1997, European journal of pharmacology.

[26]  S. Bannai,et al.  Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. , 1995, The Biochemical journal.

[27]  K. Negishi,et al.  A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion , 1992, Neuroscience.

[28]  Y. Yoneda,et al.  Localization of [3H]glutamate binding sites in rat adrenal medulla , 1986, Brain Research.

[29]  Y. Yoneda,et al.  [3H]Glutamate binding sites in the rat pituitary , 1986, Neuroscience Research.

[30]  S. Bannai Exchange of cystine and glutamate across plasma membrane of human fibroblasts. , 1986, The Journal of biological chemistry.

[31]  M. Yahr,et al.  Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. , 1982, Science.

[32]  J. Fischer,et al.  Effect of Jejunoileal Bypass on Plasma and Brain Amino Acids in the Rat , 1982, Journal of neurochemistry.

[33]  H. Kornhuber,et al.  Increased serum glutamate in depressed patients , 2004, Archiv für Psychiatrie und Nervenkrankheiten.